Arxada news

18 November 2021
Arxada Invests CHF 20m in Czech Biotech Plant
The investment will enhance infrastructure, expand technological options, and increase formulation capacity to support a growing customer base and accelerate project development.

What's Arxada up to in Europe?

Find out with chemXplore Analytics